Clinical Trial Update: National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups

View source ↗

Summary

AstraZeneca-sponsored national survey on coronary artery disease and heart failure completed in two patient groups.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure

Snippet

Sponsor: AstraZeneca | Conditions: Coronary Patients, Heart Failure | Status: COMPLETED